Wellington Management Group
DAWN

Wellington Management Group’s Day One Biopharmaceuticals DAWN Stock Holding History

Wellington Management Group’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-731,303
Closed -$9.27M – 1966
2024
Q4 		$9.27M Buy
731,303
+9,722
+1% +$135K ﹤0.01% 1214
2024
Q3 		$10.1M Buy
721,581
+423,543
+142% +$6.04M ﹤0.01% 1172
2024
Q2 		$4.11M Buy
298,038
+25,921
+10% +$379K ﹤0.01% 1362
2024
Q1 		$4.5M Buy
272,117
+63,148
+30% +$945K ﹤0.01% 1348
2023
Q4 		$3.05M Buy
208,969
+91,393
+78% +$1.11M ﹤0.01% 1408
2023
Q3 		$1.44M Buy
117,576
+5,566
+5% +$72.6K ﹤0.01% 1539
2023
Q2 		$1.34M Buy
+112,010
New +$1.46M ﹤0.01% 1558

Other funds holding DAWN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
ECM
Estuary Capital Management Wayzata, Minnesota $598M AUM 1.72% 1-Year Est. Return

Wellington Management Group's DAWN Position: Q1 2025 in Review

Wellington Management Group sold out of Day One Biopharmaceuticals (DAWN) in Q1 2025, closing a stake of 731,303 shares — an estimated $9.27M sold.

Wellington Management Group first reported a position in DAWN in Q2 2023 and held it in 7 quarters. The position peaked at $10.1M in Q3 2024. 184 funds tracked by Wall St. Rank hold DAWN as of Q1 2025.

  • Wellington Management Group reported no remaining Day One Biopharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Wellington Management Group sold 731,303 Day One Biopharmaceuticals shares in Q1 2025, an estimated $9.27M.
  • Wellington Management Group first reported a position in Day One Biopharmaceuticals in Q2 2023 and held it in 7 quarters.
  • Wellington Management Group's Day One Biopharmaceuticals position peaked at $10.1M in Q3 2024.
  • 184 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2025.

Based on Wellington Management Group's 13F filing for Q1 2025, filed 13 May 2025.